Astrotech (DE) (ASTC) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Astrotech (DE) (ASTC) has outperformed Quanterix (QTRX) over the past year, gaining 28.2% versus a loss of 70.6%. Over five years, ASTC leads with a -85.6% price change compared with -95.4% for QTRX. Quanterix is the larger company by market cap ($93.1 million vs $7.4 million), about 12.5 times the size.
Quanterix converts more of its revenue into profit, with a net margin of -77.1% versus -1580.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTC | QTRX |
|---|---|---|
| Share price | $3.50 | $1.96 |
| Market cap | $7.45M | $93.06M |
| 1-day change | -0.85% | -3.45% |
| YTD return | +1.16% | -69.18% |
| 1-year return | +28.21% | -70.57% |
| 5-year return | -85.60% | -95.45% |
| EPS (TTM) | $-7.88 | $-2.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $913.00K | $138.90M |
| Revenue growth (YoY) | -8.70% | +1.07% |
| Net income (latest FY) | $-14.43M | $-107.15M |
| Gross margin | 23.77% | 46.77% |
| Operating margin | -1548.52% | -90.38% |
| Net margin | -1580.18% | -77.14% |
| 52-week high | $68.85 | $8.77 |
| 52-week low | $1.92 | $1.77 |
| Distance from 52-week high | -94.92% | -77.65% |
| Analyst consensus | — | hold |
| Avg. price target upside | — | +69.90% |
| Average volume | 30.46K | 721.60K |
| Shares outstanding | 2.13M | 47.48M |
| Employees | — | 450 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Quanterix is about 12.5 times larger than Astrotech (DE) by market value ($93.06M vs $7.45M).
- ASTC has outperformed QTRX by 98.8 percentage points over the past year.
- Quanterix is more profitable, keeping -77.1 cents of every revenue dollar as net income versus -1580.2 cents for Astrotech (DE).
- Quanterix grew revenue faster in its latest fiscal year (+1.07% vs -8.70%).
About Astrotech (DE)
ASTC stock →Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology.
Industrials · Biotechnology: Laboratory Analytical Instruments
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
ASTC vs QTRX FAQ
Which is bigger, Astrotech (DE) or Quanterix?
Quanterix (QTRX) is larger, with a market capitalization of $93.06M compared with $7.45M for Astrotech (DE) (ASTC).
Which stock has performed better over the past year, ASTC or QTRX?
ASTC returned +28.21% over the past 12 months, compared with -70.57% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Astrotech (DE) and Quanterix in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.